Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Nucleolus

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dietary omega-6 lipids promote post-injury aberrant bone formation in obesity.

The Journal of clinical investigation·2026

Same author

Preclinical Efficacy and Safety Study of a Novel Dermal Fibroblast Modulating Drug, SLI-F06, in Cutaneous Wound Healing.

MedComm·2026

Same author

Sensory nerves protect against preclinical tendinopathic changes through FGF1 signaling.

Science translational medicine·2026

Same author

Sex-dependent mechanisms of temporomandibular joint osteoarthritis.

JBMR plus·2026

Same author

Boosting Sensory Nerve-to-Bone Interactions Enhances Hedgehog Mediated Calvarial Bone Repair.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Same author

Aging brain, brittle bone.

Trends in neurosciences·2026

Search research articles

Related Experiment Video

Updated: Apr 16, 2026

Zebrafish Model of Neuroblastoma Metastasis

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

NELL-1 expression in benign and malignant bone tumors.

Jia Shen¹, Greg LaChaud¹, Kevork Khadarian²

¹Division of Growth and Development and Section of Orthodontics, School of Dentistry, University of California, David Geffen School of Medicine, 10833 Le Conte Ave., 13-145 CHS, Los Angeles, CA 90095, USA; Department of Pathology and Laboratory Medicine, University of California, David Geffen School of Medicine, 10833 Le Conte Ave., 13-145 CHS, Los Angeles, CA 90095, USA.

Biochemical and Biophysical Research Communications

|March 21, 2015

Summary

NELL-1 (NEL-like Protein 1) is a bone-forming protein. Its expression is reliable in benign bone tumors but reduced in osteosarcoma, suggesting diagnostic potential for bone neoplasms.

Keywords:

Nell-1 Osteoblastoma Osteoid osteoma Osteosarcoma

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

Published on: March 7, 2011

Related Experiment Videos

Last Updated: Apr 16, 2026

Zebrafish Model of Neuroblastoma Metastasis

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

Published on: March 7, 2011

Area of Science:

Orthopedics
Oncology
Biochemistry

Background:

NELL-1 (NEL-like Protein 1) is an osteoinductive protein with demonstrated bone-forming capacity.
Its overexpression in cranial sutures first indicated its role in bone formation.
Recombinant NELL-1 has successfully induced bone formation in various skeletal sites in preclinical models.

Purpose of the Study:

To investigate the expression of NELL-1 in a diverse range of benign and malignant bone-forming skeletal tumors.
To evaluate the potential diagnostic and prognostic significance of NELL-1 in bone neoplasms.

Main Methods:

Immunohistochemical analysis of NELL-1 expression in human bone tumor pathological specimens.
Quantitative RT-PCR to assess NELL-1 expression levels in osteosarcoma cell lines in vitro.
Correlation of NELL-1 expression with osteogenic differentiation markers.

Main Results:

NELL-1 was expressed in all examined bone tumors, with increased expression in osteosarcoma cell lines compared to bone marrow stromal cells.
Benign bone tumors (osteoid osteoma, osteoblastoma) showed strong, diffuse NELL-1 staining correlating with osteogenic markers.
Osteosarcoma exhibited reduced and more variable NELL-1 expression, which did not consistently correlate with osteogenic differentiation markers. Fibroblastic osteosarcoma showed the highest NELL-1 expression among subtypes.

Conclusions:

NELL-1 expression is diffuse and consistent in benign bone-forming tumors but reduced in malignant osteosarcomas.
NELL-1 may serve as a potential biomarker for differentiating benign from malignant bone neoplasms.
Further research is needed to elucidate the full biological, diagnostic, and prognostic implications of NELL-1 in bone tumors.